Tuberculosis prevention among young people

DOI: https://doi.org/10.29296/25877305-2020-07-09
Download full text PDF
Issue: 
7
Year: 
2020

O. Baronova(1), Candidate of Medical Sciences; Professor K. Amlaev(2), MD; L. Rudomakha(1)
(1)Territorial Clinical Tuberculosis Dispensary, Stavropol (2)Stavropol State Medical University

The paper analyzes the spread of latent tuberculosis infection among young people. It has been established that the use of the recombinant tuberculosis allergen test and spiral computed tomography can detect both latent tuberculosis infection and post-tuberculosis changes. Preventive treatment with antituberculosis drugs stops active pulmonary tuberculosis in persons with latent TB infection. Informing university students about getting tuberculosis and its prevention contributes to the formation of commitments to prevention studies and prophylactic therapy.
Keywords: 
phthisiology
tuberculosis
students
latent tuberculosis infection
recombinant tuberculosis allergen test
preventive treatment

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Vsemirnaja organizatsija zdravoohranenija. Strategija VOZ po likvidatsii tuberkuleza: tseli i pokazateli, 2013 [Vsemirnaya organizatsiya zdravookhraneniya. Strategiya VOZ po likvidatsii tuberkuleza: tseli i pokazateli, 2013 (in Russ.)]. URL: https://www.who.int/tb/strategy/ru/
  2. Vsemirnaja organizatsija zdravoohranenija. Rukovodstvo po vedenie patsientov s latentnoj tuberkuleznoj infektsiej. Zheneva, 2015 [Vsemirnaya organizatsiya zdravookhraneniya. Rukovodstvo po vedenie patsientov s latentnoi tuberkuleznoi infektsiei. Zheneva, 2015 (in Russ.)].
  3. Litvinov V.I. Chto takoe latentnaja tuberkuleznaja infektsija: vzgljad na problemu. Tuberkulez i sotsial'no-znachimye zabolevanija. 2017; 2: 6–9 [Litvinov V.I. Chto takoe latentnaya tuberkuleznaya infektsiya: vzglyad na problem. Tuberkulez i sotsial’no-znachimye zabolevaniya. 2017; 2: 6–9 (in Russ.)].
  4. Fatyhova R.H., Alekseev A.P. Effektivnost' skriningovyh obsledovanij detskogo naselenija na nalichie tuberkuleznoj infektsii v Respublike Tatarstan. Tuberkulez i bolezni legkih. 2016; 6: 39–42 [Fatykhova R.K., Alekseev A.P. Efficiency of screening for tuberculous infection among children in Tatarstan Republic. Tuberculosis and Lung Diseases. 2016; 94 (6): 39–42 (in Russ.)]. https://doi.org/10.21292/2075-1230-2016-94-6-39-42
  5. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju latentnoj tuberkuleznoj infektsii u detej. M.: ROOI «Zdorov'e cheloveka», 2015; 36 s. [Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu latentnoi tuberkuleznoi infektsii u detei. M.: ROOI «Zdorov’e cheloveka», 2015; 36 s. (in Russ.)].
  6. Salinas C., PascualErquicia S., Diez R. et al. Three-mounth course of rifampicin and isoniazid for the treatment of latent tuberculosis infection. Med Clin. 2019; 135 (7): 9–293. DOI: 10.1016/j.medcli.2010.02.038
  7. Aksenova V.A., Levi D.T., Aleksandrova N.V. i dr. Sovremennoe sostojanie voprosa zabolevaemosti detej tuberkulezom, preparaty dlja profilaktiki i diagnostiki infektsii. Biopreparaty. Profilaktika, diagnostika, lechenie. 2017; 17 (3): 145–51 [Aksenova V.A., Levi D.T., Aleksandrova N.V. et al. Current tuberculosis incidence among children; medicines for prevention and diagnosis of TB. Biopreparations. Prevention, Diagnosis, Treatment. 2017; 17 (3): 145–51 (in Russ.)].
  8. Slogotskaja L.V., Sinitsyn M.V., Kudlaj D.A. Vozmozhnosti immunologicheskih testov v diagnostike latentnoj tuberkuleznoj infektsii i tuberkuleza. Tuberkulez i bolezni legkih. 2019; 97 (11): 46–59 [Slogotskaya L.V., Sinitsyn M.V., Kudlay D.A. Potentialities of immunological tests in the diagnosis of latent tuberculosis infection and tuberculosis. Tuberculosis and Lung Diseases. 2019; 97 (11): 46–58 (in Russ.)]. DOI: 10.21292/2075-1230-2019-97-11-46-58
  9. Starshinova A.A., Kudlaj D.A., Dovgaljuk I.F. i dr. Effektivnost' primenenija novyh metodov immunodiagnostiki tuberkuleznoj infektsii v Rossijskoj Federatsii. Pediatrija. 2019; 98 (4): 229–35 [Starshinova A.A., Kudlay D.A., Dovgalyuk I.F. et al. Efficacy of new methods of tuberculosis infection immunodiagnostics in the Russian Federation. Pediatria. 2019; 98 (4): 229–35 (in Russ.)]. DOI: 10.24110/0031-403X-2019-98-4-229-235
  10. Shovkun L., Aksenova V., Kudlay D. et al. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA). Eur Resp J. 2018; 52 (S62): PA2733.
  11. Slogotskaya L.V., Bogorodskaya E., Sentchichina O. et al. Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children. Eur Resp J. 2015; 46 (S59): RA4524.
  12. Slogotskaya L.V., Litvinov V., Ovsyankina E., et al. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection. Paediatr Resp Rev. 2013; 14 (2): S65.
  13. Slogotskaya L.V., Litvinov V., Kudlay D.A. et al. New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection. Eur Resp J. 2012; 40 (S56): 416.
  14. Goswami N., Gadkowski L., Piedrahita C. et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012; 12: 468. DOI: 10.1186/1471-2458-12-468
  15. Horsburgh C., Goldberg S., Bethel J. et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010; 137 (2): 401–9. DOI:10.1378/chest.09-0394
  16. Trajman A., Long R., Zylberberg D. et al. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis. 2010; 14 (5): 551–9.